BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7912842)

  • 21. CD4 counts as surrogate markers for progression to AIDS.
    Hirschel B
    Ann Intern Med; 1994 Jan; 120(1):87; author reply 88. PubMed ID: 7902687
    [No Abstract]   [Full Text] [Related]  

  • 22. Consensus symposium on combined antiviral therapy; overview of interferon and IL-2 combinations for the treatment of HIV infection.
    Sneller MC
    Antiviral Res; 1996 Jan; 29(1):105-9. PubMed ID: 8721559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
    Lancet; 1994 Apr; 343(8902):871-81. PubMed ID: 7908356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zidovudine in asymptomatic HIV infection.
    Berger PB
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 7902534
    [No Abstract]   [Full Text] [Related]  

  • 26. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of zidovudine dosing.
    Stoukides CA; Cichocki TJ
    Ann Pharmacother; 1992 Jun; 26(6):784-5. PubMed ID: 1351766
    [No Abstract]   [Full Text] [Related]  

  • 28. Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?
    Ruedy J; Schechter M; Montaner JS
    Ann Intern Med; 1990 May; 112(10):721-3. PubMed ID: 1970465
    [No Abstract]   [Full Text] [Related]  

  • 29. Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.
    BMJ; 1992 Jan; 304(6818):13-7. PubMed ID: 1346505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV surrogate markers weighed.
    Cotton P
    JAMA; 1991 Mar; 265(11):1357, 1361-2. PubMed ID: 1671883
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiretroviral therapy. Current status and perspectives].
    Lüthy R
    Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
    [No Abstract]   [Full Text] [Related]  

  • 32. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleak news from the AIDS front.
    Berger PB
    CMAJ; 1993 Oct; 149(7):1016-8. PubMed ID: 8104677
    [No Abstract]   [Full Text] [Related]  

  • 34. Population dynamics of HIV within an individual after treatment with zidovudine.
    McLean AR; Emery VC; Webster A; Griffiths PD
    AIDS; 1991 May; 5(5):485-9. PubMed ID: 1677807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.
    Hamilton JD; Hartigan PM; Simberkoff MS; Day PL; Diamond GR; Dickinson GM; Drusano GL; Egorin MJ; George WL; Gordin FM
    N Engl J Med; 1992 Feb; 326(7):437-43. PubMed ID: 1346337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV and AIDS.
    Caswell A
    Med J Aust; 1992 Jul; 157(2):138-9. PubMed ID: 1352847
    [No Abstract]   [Full Text] [Related]  

  • 37. [Several aspects of HIV infections].
    Costantino M
    Minerva Chir; 1991 Oct; 46(20):1152. PubMed ID: 1766567
    [No Abstract]   [Full Text] [Related]  

  • 38. Open trial of tacrine therapy in 70 HIV-infected patients.
    Fredj G; Dietlin F; Jasmin C; Maurisson G; Barbier M; Bayce P; Ratiney R; Rudant E; Debat P; Kalifa D
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):313-6. PubMed ID: 1358832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could drugs, rather than a virus, be the cause of AIDS?
    Cohen J
    Science; 1994 Dec; 266(5191):1648-9. PubMed ID: 7992047
    [No Abstract]   [Full Text] [Related]  

  • 40. A fight to the death.
    Short N
    Nat Med; 1995 Feb; 1(2):122-4. PubMed ID: 7585006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.